Year of point prevalence study | MRSA | VRE | ESBL-EC (2012) 3MRGN-EC (2014) | ESBL-KS (2012) 3MRGN-KP* (2014) | CD | |||||
---|---|---|---|---|---|---|---|---|---|---|
Mean prevalence [95 % CI] | Mean prevalence [95 % CI] | Mean prevalence [95 % CI] | Mean prevalence [95 % CI] | Mean prevalence [95 % CI] | ||||||
2012 [12] | 1.53 | [1.32 – 1.75] | 0.27 | [0.18 – 0.36] | 0.97 | [0.80 – 1.14] | 0.33 | [0.19 – 0.48] | 1.30 | [1.11 – 1.50] |
2014 | 1.64 | [1.46 – 1.82] | 0.25 | [0.13 – 0.37] | 0.75 | [0.60 – 0.89] | 0.22 | [0.15 – 0.29] | 0.74 | [0.60 – 0.88] |